Tirzepatide
99.5% Purity
Royal Grade
Weightloss
Tirzepatide
Dual GIP/GLP-1 Agonist · 5mg
$99.99CAD · per vial
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for energy balance and glycemic control in metabolic research.
Dual GIP/GLP-1 appetite suppression
Improved insulin sensitivity
Significant fat loss
Vial Size
1
Lab tested
Canada-wide shipping
Secure checkout
Research grade
For research use only. Not for human consumption, medical, veterinary, or household use. 18+ only.
Research Applications
- Energy balance
- Glycemic control
- Adipose tissue models
Recommended Research Dosage
2.5–15 mg once weekly (subcutaneous, titrated up)
Suggested protocol from peer-reviewed peptide literature. Always begin at the lowest dose and titrate up under qualified supervision.
BAC Water Reconstitution
For your selected 5mg vial
1.5 mL BAC water
Concentration: 3.33 mg / mL
Choose BAC water volume
10 units (0.1 mL)
333 mcg
20 units (0.2 mL)
666 mcg
Insulin syringe = U-100. Slowly drip BAC water down the inside of the vial — never inject force. Swirl, do not shake.